Site Search
Displaying results 181 - 190 of 573
Resource | Publications,
The advent of point-of-care (POC) EID technologies is a breakthrough that creates the opportunity to increase coverage of EID testing. It will allow same-day test results and enable the initiation of earlier treatment, as well as address some of the key limitations of conventional EID networks – in particular long turnaround times for tests and high rates of loss to follow up.
Resource | Guidelines,
This publication provides guidance on the public health response to pretreatment HIV drug resistance (HIVDR) to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) among people without prior antiretroviral (ARV) drug exposure or people with prior ARV exposure who are initiating or reinitiating first-line antiretroviral therapy (ART). It also provides the consensus prevalence or threshold of pretreatment HIVDR to NNRTIs at which specific public health actions are triggered. This publication is a supplement to Chapter 4 of the 2016 WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (2016 WHO consolidated ARV guidelines).
Resource | Tools,
This implementation tool describes the recommended approaches for routine monitoring of toxicity integrated with the national monitoring and evaluation system and targeted approaches to monitoring toxicity to enable enhanced monitoring and reporting of treatment-limiting toxicity to support country implementation and generation of local data.
In addition to recognizing the linkages, coinfected populations and commonalities across TB, hepatitis B and C and with the aim of encouraging integration, this tool also highlights the recommended toxicity monitoring approaches and existing tools across these disease areas.
Resource | Fact Sheets,
With the 2016 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, WHO updated and launched new policy recommendations on the clinical and service delivery aspects of HIV treatment and care, and raised the bar to treat all PLHIV (Treat All). WHO has worked with countries to ensure uptake and implementation of these recommendations in support of the to the 90-90-90 targets.
This fact sheet present data for 194 WHO Member States – including 138 low- and middle-income countries (LMIC) – and 35 Fast‑Track countries, respectively through July 2017.
Resource | Publications,
This second HIV Drug Resistance (HIVDR) report has been jointly developed by WHO, the United States Centers for Disease Control and Prevention (US-CDC) and the Global Fund to Fight AIDS, Tuberculosis and Malaria (“The Global Fund”). It provides an update on recent population levels of HIVDR covering the period 2014–2016. The report includes data from 16 nationally representative surveys from 14 countries1 estimating resistance in: adults initiating ART (PDR), children younger than 18 months newly diagnosed with HIV, and adults on ART (acquired HIV drug resistance or ADR).
Guidelines for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy: Annexes
Resource | Reviews and Snapshots,
The aim of this review was to determine if packaged interventions, which include enhanced infection prophylaxis, screening, and other elements of care delivered together, can improve outcomes in HIV-positive patients presenting with advanced disease.
Resource | Publications,
Viral hepatitis is more prevalent in Asia than other regions. From the survey done among the general population in 2015 in Myanmar, the prevalence of hepatitis B was 6.5% and hepatitis C was 2.7%.
The 67th World Health Assembly in May 2014 approved a resolution to improve the prevention, diagnosis and treatment of viral hepatitis. In November 2014, Myanmar initiated the establishment of a National Hepatitis Control
Program (NHCP) following the resolution set up by the World Health Organization (WHO).
Myanmar is taking a public health approach to the treatment and care of viral hepatitis, treating not only mono-infected patients but also those co-infected with HIV, in line with the WHO’s strategic directions and the National Clinical Treatment Guidelines.
Resource | Publications,
WHO guidelines issued on HIV prevention, diagnosis, treatment and care for key populations (8), and on HIV testing services (11) included annexes that presented examples of innovative programmes around the world that seek to increase access to vital health and supportive services for communities with the greatest vulnerabilities to HIV, and to protect the rights of those key populations. This compilation joins those two annexes, providing updated information and additional details on programmes when available, and considering the aspects of differentiated service delivery that are key to the success of these programmes.
The case examples included in this document have been submitted and described by the programmes themselves. WHO has not conducted evaluations of these programmes and their results. They have been included on the basis of a set of selection criteria for good practice examples of overcoming challenges and structural barriers to service provision for key populations.
Resource | Publications,
This document is the fifth set of strategies developed by the Hong Kong Advisory Council on AIDS (ACA) since 1994. The process of its formulation adopted a wide-based approach of engaging different parties, including Community Stakeholders’ Consultation and gathering the input of individuals, groups and organizations as well as the general public during the subsequent public consultation.
Hong Kong has fortunately maintained a low HIV infection rate for 3 decades since the first reported case in 1984. The Government, NGOs, the community and other stakeholders work collectively on a comprehensive AIDS programme which encompasses surveillance, health promotion and HIV prevention, treatment and care, and is underpinned by policy-setting and programme funding.
The objectives laid down in the Strategies are in line with the 90-90-90 treatment targets together with the 90% coverage of HIV combination prevention services set by the UNAIDS.